Back

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

25 August 2023 (15:15 - 15:45)
Organised by: Logo
Congress Presentation Part of: Pharmacological therapy in heart failure (1) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Michele Golino

University of Florida College of Medicine – Jacksonville, Jacksonville (United States of America)

5 More presentations in this session

Presentation thumbnail
Torsemide versus furosemide in patients with heart failure: a systematic review and updated meta-analysis of randomised controlled trials
Doctor L. Figueiredo Teixeira (Campina Grande, BR)
Abstract Slides Video
Presentation thumbnail
Modelling clinicians' decisions to adjust loop diuretic dose based on patient-reported symptoms to inform decision-aids in daily care of chronic heart failure
Ms A. Bruninx (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Comparison study of olmesartan and valsartan on myocardial metabolism in patients with dilated cardiomyopathy trial
Professor K. Park (Busan, KR)
Abstract Slides Video
Presentation thumbnail
Efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes in older patients: a systematic review and meta-analysis.
Doctor T. Fujisaki (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Sex differences for the efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: a systematic review and meta-analysis.
Doctor T. Fujisaki (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacological therapy in heart failure (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of anakinra on patients with heart failure below and above 60 years of age
thumbnail
Congress Presentation
Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra
thumbnail
Congress Session
Insights from recent HFpEF trials 1

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources